Tenoric

Quick links to important sections

Tenoric

Selected form

Medically reviewed

Rosario Oropesa

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Tenoric

Property Description
Active Ingredients Atenolol, Chlorthalidone
Form Oral Tablet
Pharmacological Class Antihypertensive (Beta-blocker and Diuretic combination)
General Purpose Management of high blood pressure
Origin Synthetic

What Type of Medicine is Atenolol/Chlorthalidone?

Atenolol/Chlorthalidone is a prescription-only medication categorized as a fixed-dose combination product in the antihypertensive pharmacological class. It is a synthetic preparation designed for the long-term management of elevated blood pressure in a single oral tablet. This combination approach is a clinically recognized strategy of combining two different classes of agents to achieve pressure control. This medicine belongs to a foundational group of cardiovascular agents whose purpose is to provide consistent, stable support for vascular health.


The Composition: Atenolol and Chlorthalidone

The composition relies on two distinct active ingredients: the INN entities Atenolol and Chlorthalidone. Atenolol is classified as a beta1-selective adrenoceptor blocking agent (a beta-blocker). Chlorthalidone, the second agent, is a thiazide-like diuretic, a compound that helps the body remove excess salt and fluid. The fixed-dose format is a distinguishing factor, ensuring the precise co-administration of both agents simultaneously, which is often preferred by clinicians to simplify patient regimens compared to requiring two separate tablets.


Why Use a Dual-Action Combination?

The main general purpose is to achieve therapeutic synergism—a combined effect that is stronger than either single ingredient alone—to provide stable blood pressure control. This strategy is effective because Atenolol reduces the force and rate of the heart's pumping action, simultaneously complementing Chlorthalidone, which promotes the excretion of excess salt and water. By managing both the heart's workload and the total circulating fluid volume, this dual-action medicine provides foundational cardiovascular support necessary for maintaining long-term blood pressure health.

Regulatory References

  1. FDA Labeling Information
  2. antihypertensive
  3. PubChem
  4. adrenoceptor blocking agent
  5. thiazide-like diuretic

What side effects are possible with Tenoric?

Possible Side Effects and Safety Information

The safety profile of Atenolol/Chlorthalidone is structured around regulatory classifications detailing adverse reactions and constraints on use, as documented by official government health authorities.

Adverse effects are categorized by frequency and the System-Organ Class (SOC) affected. Common reactions often involve the Cardiac and Vascular Disorders systems, including bradycardia (slowed heart rate), fatigue, cold extremities, and orthostatic hypotension. Effects categorized as Rare include mood changes, hallucinations, impotence, and reversible alopecia.

Classification Examples of Adverse Reactions (by Regulatory Classification)
Common Bradycardia, fatigue, cold extremities, gastrointestinal disturbances.
Rare Mood changes, confusion, impotence, dry eyes, reversible alopecia.

Serious adverse reactions documented in regulatory sources include the potential for deterioration of heart failure, precipitation of heart block, and severe electrolyte imbalances such as hypokalaemia and hyponatraemia, particularly related to the diuretic component. Pancreatitis and rare blood disorders are also noted.

Safety limitations restrict use in individuals with severe bradycardia, second or third-degree heart block, cardiogenic shock, anuria, or known hypersensitivity to sulfonamide-derived drugs. Safety information also specifies that the dose requires careful consideration in populations with severe renal impairment due to the risk of accumulation, and caution is needed in those with severe hepatic impairment.

Overdose and Emergency Response

Overdose and When to Seek Help

Overdosage with this medicine may lead to severe clinical manifestations resulting from the combined effects of profound beta-blockade and excessive fluid and electrolyte loss. Immediate medical attention is required for any suspected overdose.


Documented Manifestations

Overdose presentations documented in regulatory labeling include symptoms of severe cardiovascular depression and metabolic imbalance. Key signs may include pronounced bradycardia (slow heart rate), significant hypotension (low blood pressure), and sinus pause. Severe outcomes such as congestive heart failure and disorder of respiratory drive have been reported for the beta-blocker component.

From the diuretic component, official documents list signs of critical fluid and electrolyte derangement, including lethargy, weakness, muscle pains or cramps, and oliguria (decreased urination). Laboratory findings of overdose may feature severe hypoglycemia (low blood sugar), hypokalemia, and hyponatremia.


Emergency Action and Management

Government guidance mandates that immediate medical help be sought when symptoms such as severe hypotension, acute cardiac failure, or respiratory distress are present. No specific antidote is known for the Atenolol component. Management described in regulatory labeling is symptomatic and supportive, focused on removing unabsorbed drug using measures such as activated charcoal or gastric lavage. Specialized treatment may involve vasopressors to manage hypotension or the use of hemodialysis to clear Atenolol.

Therapeutic Uses of Tenoric

Quick Facts: Uses of Tenoric

  • Condition Managed: High blood pressure (hypertension).
  • Therapeutic Goal: Supporting the management of sustained high blood pressure levels.
  • Benefit: Contributes to blood pressure reduction, which is associated with a lower risk of certain cardiovascular events.

What Tenoric Treats: Main Uses and Benefits

Tenoric is a prescription medication utilized in the management of high blood pressure, a chronic health condition also known as hypertension. It is typically reserved for patients whose blood pressure levels are not adequately addressed by treatment with a single medication.

The therapeutic purpose of administering Tenoric is to support the reduction of elevated blood pressure. The combination of its components helps to contribute to this overall reduction. Lowering high blood pressure levels is an established component of comprehensive cardiovascular risk management. This reduction is associated with helping to reduce the risk of certain serious cardiovascular events, such as stroke and heart attack, by decreasing the workload on the heart and blood vessels.

Treatment with this medication is generally considered to be a component of a larger strategy that may also involve lifestyle adjustments, dietary modifications, and other therapeutic interventions, as determined by a healthcare provider. The appropriate uses of this product are defined in its product information and are directed toward the treatment of hypertension.

This medication is not indicated for the initial treatment of hypertension and is intended for use when the individual component doses are already appropriate for a patient's needs, offering a formulation that supports the continuation of established therapy.

Eligibility and Restrictions for Use

Eligibility Map: Who Can and Cannot Use Tenoric

Official regulatory documentation for Tenoric (Atenolol/Chlorthalidone) strictly defines the eligible population and conditions for use.

Eligibility Status Patient/Condition
Contraindicated (Must Not Use) Sinus Bradycardia or heart block greater than first degree
Cardiogenic Shock or Overt Cardiac Failure
Anuria or Severe Renal Failure
Pregnancy or Lactation
Hypersensitivity to components or sulfonamide-derived drugs
Restricted/Caution Impaired Renal or Hepatic Function (non-severe)
Bronchospastic Disease (e.g., asthma)
Diabetes Mellitus, Untreated Pheochromocytoma, or Systemic Lupus Erythematosus
Age Group Rule Adults only; safety and efficacy have not been established in the pediatric population (under 18 years of age)

The medicine is generally restricted to adults with hypertension and is not indicated for initial therapy. Regulatory labels impose absolute contraindications for severe cardiac conditions and fluid imbalance. Use requires specific caution for patients with existing organ impairment or certain metabolic and respiratory comorbidities.

What should I know about interactions with other medicines?

Interactions with other medicines and products

This medication’s official interaction profile is characterized by pharmacodynamic and pharmacokinetic considerations documented in regulatory labeling. The co-administration of Digitalis glycosides or certain Calcium Channel Blockers (e.g., Verapamil, Diltiazem) is officially associated with an additive effect on cardiac conduction, increasing the risk of bradycardia and heart block.

Pharmacokinetic interactions exist with polyvalent cation-containing products: co-administration with Multivitamin with Minerals may lead to decreased Atenolol bioavailability due to inhibition of gastrointestinal absorption. A separation of administration by at least 2 hours is recommended to mitigate this effect. Alcohol co-ingestion may have additive effects in lowering blood pressure, increasing the risk of orthostatic hypotension.

In emergency settings, the Atenolol component may reduce the effects of Epinephrine used to treat severe allergic reactions. Population-specific cautions include the risk of cumulative Atenolol effects in patients with impaired renal function and the potential for the drug to mask the early signs of hypoglycemia in diabetic patients, as stated in the official regulatory documents.

Mechanism of Action

The action of Tenoric, a fixed-dose combination, is achieved by influencing two distinct physiological systems—the heart and the kidneys—resulting in a coordinated modulation of systemic hemodynamics. This dual mechanism modulates both the force of cardiac output and the total volume of fluid circulating in the body.

Modulating Cardiac Sympathetic Control

The component Atenolol acts on mathbfbeta1-adrenergic receptors located primarily in the heart. By competitively blocking these receptors, it inhibits the stimulating effects of catecholamines (adrenaline and noradrenaline), causing a reduction in both the heart's rate and its contractile force. This mechanistic domain acts to lower the total volume of blood ejected per minute (mathbfCardiac~Output), which contributes to a reduction in systemic vascular tension and suppresses the release of renin .

Adjusting Renal Volume and Electrolyte Balance

The component Chlorthalidone inhibits the mathbf Na^+/ Cl^-~Symporter in the distal convoluted tubule of the kidney. This blockade prevents the reabsorption of sodium and chloride, leading to increased excretion of salt and water (diuresis). This mechanism decreases the overall circulating Plasma Volume and is associated with a long-term reduction in Peripheral Vascular Resistance, providing a second, volume-dependent contribution to systemic hemodynamic modulation .

Dosage and Administration Information

The fixed-dose combination of Atenolol and Chlorthalidone is administered orally as a tablet and is taken once daily. This medication is supplied in two specific fixed-dose strengths: 50 mg Atenolol with 25 mg Chlorthalidone, and 100 mg Atenolol with 25 mg Chlorthalidone. The tablet may be administered with or without food.


Administration Protocol

The combination product is not indicated for the initial treatment of high blood pressure; its use is typically reserved for maintenance therapy after a patient's individual dose requirements have been established. The usual starting dose is the 50 mg/25 mg tablet taken once a day. If a sufficient response is not achieved, the dose may be increased to the 100 mg/25 mg strength taken once daily. The maximum daily dose for the Atenolol component, regardless of the combination strength, should not exceed 100 mg. When discontinuing the medication, it is recommended that therapy be withdrawn gradually over a period of approximately two weeks.


Population-Specific Use Adjustments

Dose modifications are indicated for individuals with impaired renal function, as the Atenolol component accumulates when creatinine clearance (CrCl) falls below 35 mL/min/1.73 m^2.

Creatinine Clearance (CrCl) Maximum Atenolol Component Dosage
15–35 mL/min/1.73 m^2 50 mg once daily
< 15 mL/min/1.73 m^2 50 mg every other day

The safety and effectiveness of the combination product have not been established for use in pediatric patients (under 18 years).

Recent Clinical Evidence

Research Evidence / Overview of Studies for Tenoric


Evidence for Use in High Blood Pressure (Hypertension)

Research exploring Tenoric, which combines atenolol and chlorthalidone, has focused primarily in research exploring management of elevated blood pressure, also known as hypertension. Studies conducted during periods of increased symptom activity were designed to monitor the change associated with the fixed-dose combination compared to a placebo or to its individual components given separately. These short-term Randomized Controlled Trials (RCTs) were used in research examining temporary physiological imbalance, specifically measuring outcomes related to systemic or functional imbalance, such as changes in Systolic and Diastolic Blood Pressure (SBP and DBP). Trials reported measurements consistent with an additive pattern in blood pressure markers when both agents were co-administered in the fixed-dose formulation.


Long-Term Evidence and Cardiovascular Outcomes

Research examining long-term health patterns, such as those related to major cardiovascular events, draws upon extensive data from trials involving the component drug classes individually. Large-scale meta-analyses and long-term RCTs involving medications like chlorthalidone were observed in studies exploring long-term outcomes like fatal or nonfatal stroke and myocardial infarction (heart attack). Findings from those studies describe patterns where blood pressure markers were associated with changes in the incidence of these serious cardiovascular events. However, dedicated, large-scale, long-term morbidity and mortality RCTs specific to the fixed-dose combination product itself were not typically the focus; the long-term evidence is primarily informed by external research.


Evidence in Specific Patient Populations

Research has applied in studies examining patient-reported experiences in older adults (aged 65 years and above) and in populations presenting with other health conditions, such as diabetes. Study results reflect the specific conditions under which they were conducted. For instance, safety and efficacy data have not been established for children (under 18 years of age). The research applies only to the populations studied, and data for pediatric use are insufficient.


Key Research Gaps and Uncertainties

There are several areas where research is still ongoing or where existing evidence is limited. The follow-up durations for the specific short-term trials of the combination product were brief, and research for long-term outcome data is often informed by external evidence. Another limitation is that some evidence analyses describe patterns where one of the component drugs, atenolol, may appear to be associated with a different long-term outcome pattern in certain populations. Comparative evidence directly assessing the fixed-dose combination against all other large-scale long-term treatments is limited.

Frequently Asked Questions (FAQ)

Common questions about Tenoric (FAQ)

Q: Why did my doctor prescribe Tenoric instead of a single blood pressure pill?

According to the official product information, Tenoric is a fixed-dose combination of two different blood pressure medicines: a beta-blocker and a diuretic. This combination is a strategy often used for maintenance therapy to achieve therapeutic synergism, meaning the combined effect can be greater than either ingredient alone. This supports the long-term management of high blood pressure.

Q: What's the difference between Tenoric and just taking the two ingredients separately?

The key difference is the fixed-dose format of Tenoric. This ensures that both active ingredients are combined into a single oral tablet and administered simultaneously. The fixed-dose combination can be a strategy to simplify the number of tablets a patient takes.

Q: How quickly should I expect Tenoric to start working?

Studies and official information indicate that while the initial effects of the medication may begin within about one hour of administration, it typically takes one to two weeks for the full blood pressure-lowering benefit to be achieved. Consistent daily use is typically part of achieving stable blood pressure control.

Q: What happens if I miss a dose of Tenoric?

Regulatory guidance addresses missed doses, advising that if a dose is missed, it should be taken as soon as it is remembered. However, if it is close to the time for the next dose, the guidance is generally to skip the missed dose to prevent taking a double amount.

Q: Can Tenoric make you feel tired or dizzy?

Yes, regulatory documents list fatigue and general tiredness as common adverse reactions. Dizziness is also noted, and this side effect is often related to the intended blood pressure-lowering effect or when changing position, like standing up quickly.

Q: Can Tenoric be used during pregnancy or while breastfeeding?

Official product information states that this medicine is contraindicated (must not be used) during pregnancy due to the potential risk of harm to the unborn baby. It is also not recommended while breastfeeding, as the active ingredients can pass into breast milk.

Q: If my blood pressure is under control, can I stop taking Tenoric?

Official warnings emphasize that therapy should never be stopped suddenly. If a decision is made to discontinue the drug, it must be withdrawn gradually over a period of about two weeks under the guidance of a healthcare professional. It is intended for the long-term management of high blood pressure.

Q: How long do most people have to stay on Tenoric?

The medication is intended for the long-term management of elevated blood pressure. Since hypertension is typically a chronic condition, the drug is used to control the condition over an extended period.

Q: What happens if Tenoric is stopped suddenly?

Abrupt withdrawal of this type of medication, especially in patients with pre-existing heart conditions, carries the risk of worsening symptoms such as chest pain (angina) or increasing the chances of a serious cardiac event. Regulatory guidelines emphasize the necessity of gradual withdrawal.

Q: Is Tenoric safe for older adults?

Studies and official information have not demonstrated specific problems that would generally limit its use in older adults. However, because older patients are more likely to have issues with organs like the kidneys, dosage adjustment is often a consideration for proper use.

Q: Does Tenoric cause weight gain?

Unusual weight gain is included among the serious effects that should be reported to a healthcare professional immediately, as it may be a sign of worsening heart failure. Body weight changes are typically monitored when using this medication.

Q: Does Tenoric affect potassium levels?

Yes, the diuretic component of the medication is known to affect the balance of salts and minerals in the body. It can cause low potassium levels (hypokalemia), which can be serious, and monitoring of potassium levels is often necessary.

Q: Is it normal to have cold hands and feet while taking Tenoric?

Official regulatory documents list cold extremities (hands and feet) as a common side effect. This is an expected occurrence for a significant number of patients taking this medication due to the way the beta-blocker component affects circulation.

Q: Will Tenoric interact with common pain relievers like ibuprofen?

The official labeling warns that the blood pressure-lowering effect of Tenoric may be decreased when used with certain nonsteroidal anti-inflammatory drugs (NSAIDs), such as ibuprofen. The combination should be used with caution.

Q: Are there any foods or drinks I need to avoid while on Tenoric?

Regulatory information advises caution regarding the consumption of alcohol. Alcohol can cause additive effects in lowering blood pressure, increasing the risk of side effects like dizziness and lightheadedness. Consumption of alcohol should be managed in consultation with a healthcare provider.

Q: Does Tenoric interact with diabetes medications?

Official warnings note that the beta-blocker component may mask the early signs of hypoglycemia (low blood sugar), specifically a fast or racing heartbeat, in patients with diabetes. Caution is typically advised regarding blood sugar management.

Q: Does Tenoric affect athletic performance?

Common side effects, such as tiredness and fatigue, may affect a patient's exercise capacity. The medication's status in competitive sports is often managed by relevant anti-doping agencies.

Q: Can Tenoric cause stomach upset?

Yes, official safety information lists gastrointestinal disturbances as a common adverse reaction. This can include general stomach upset, nausea, and other digestive issues.

Q: Is there any research on Tenoric's effectiveness compared to other combination blood pressure drugs?

Regulatory summaries acknowledge that dedicated, large-scale comparative evidence directly assessing this fixed-dose combination against all other long-term treatments for hypertension is generally limited. The evidence for its effectiveness is primarily based on studies comparing it to placebo or its individual components.

Q: Does Tenoric affect cholesterol levels?

Official adverse reaction data indicate that one of the components (the diuretic) has the potential to cause changes in blood lipids, which include cholesterol. Monitoring of these levels may be advised during use.

Q: Does Tenoric cause or worsen depression?

Depression is listed as an adverse event associated with the use of the drug in official documents. Any feelings of sadness, worsening mood, or signs of depression are typically discussed with a healthcare provider.

Q: Is it safe to drink alcohol in moderation while on Tenoric?

Official labeling advises caution regarding alcohol consumption due to the high risk of additive effects in lowering blood pressure. This can potentially lead to increased side effects such as drops in blood pressure and dizziness, even when consuming a moderate amount.

Q: What if I'm taking herbal supplements; do they interact with Tenoric?

Since herbal remedies and supplements are not regulated or tested in the same way as prescription medications, there is not enough specific safety data to confirm that they are safe to use together. Disclosure of all supplements being taken is typically recommended.

Q: Is it normal for my heart rate to slow down on Tenoric?

Yes, bradycardia (a slowed heart rate) is a common adverse reaction that is also a direct therapeutic effect of the beta-blocker component. The slowing of the heart rate is an expected occurrence, but if the rate becomes too slow, it is typically advised to consult a healthcare provider.

Q: How does Tenoric help lower the risk of stroke or heart attack?

Official regulatory documents explain that the primary goal of the medication is to control high blood pressure. Uncontrolled high blood pressure is a major risk factor for serious cardiovascular events like stroke and heart attack. By controlling this risk factor, the drug may help make these problems less likely to occur.

How should Tenoric be stored and disposed of?

Tenoric (atenolol and chlorthalidone) must be stored according to specific regulatory requirements to maintain its stability and effectiveness.

Storage Conditions

Tenoric tablets are required to be kept at Controlled Room Temperature, which is officially defined as 20 C to 25 C (68 F to 77 F). The medication must be kept in the container it came in, tightly closed, and stored away from excess heat, moisture, and direct light. It is essential to prevent the tablets from freezing.

Child Safety and Disposal

All medication must be stored out of the reach of children to prevent accidental ingestion. For safety, always ensure the safety cap is locked. Unused or expired Tenoric must be disposed of properly by following local regulations for pharmaceutical waste, which often includes consulting a healthcare professional for guidance.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Tenoric found in:

A-Z Index: